, Tracking Stock Market Picks
Enter Symbol:
Discovery Laboratories, Inc. (DSCO) [hlAlert]

up 52.77 %

Discovery Laboratories, Inc. (DSCO) rated Sell by Wedbush Morgan

Posted on: Thursday,  Jul 2, 2009  9:37 AM ET by Wedbush Morgan

Wedbush Morgan rated Sell Discovery Laboratories, Inc. (NASDAQ: DSCO) on 07/02/2009, when the stock price was $0.55. Since
then, Discovery Laboratories, Inc. has lost 34.55% as of 01/25/2016's recent price of $0.36.
If you would have followed this Wedbush Morgan's recommendation on DSCO, you would have gained 52.77% of your investment in 2398 days.

Discovery Laboratories, Inc., formerly known as Ansan Pharmaceuticals, Inc., is a development-stage pharmaceutical company that focuses on developing compounds to treat respiratory diseases that affect the ability of the lungs to absorb oxygen. It is initially developing its lead product candidate, Surfaxin, for use by newborn infants to treat two respiratory conditions in critical care units of hospitals. The second compound under development is SuperVent, which is intended to treat airway diseases such as cystic fibrosis (CF) and chronic bronchitis.

Since 1980, WEDBUSH has used its private equity discipline to invest in under-valued and capital constrained public and private companies that have a significant potential for appreciation. The firm invests with high quality management teams with domain expertise and expects management to retain or make a personally significant equity investment.
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy